Skip to main content
VCbacked
Log inGet Started

Kinaset Therapeutics

Boston, United States

Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.

$103.0M raised
Jan 2026
Series B
Health CareMedicalTherapeutics

Top Investors

RA Capital ManagementSchroders CapitalVivo CapitalEQT Life Sciences5AM Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Kinaset Therapeutics

How much funding has Kinaset Therapeutics raised?
Kinaset Therapeutics has raised $103.0M in total funding. The most recent round was Series B. The last funding was announced in January 2026.
Who are Kinaset Therapeutics's investors?
Kinaset Therapeutics's investors include RA Capital Management, Schroders Capital, Vivo Capital, EQT Life Sciences, 5AM Ventures.
Where is Kinaset Therapeutics headquartered?
Kinaset Therapeutics is headquartered in Boston, United States.
What does Kinaset Therapeutics do?
Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.
What stage is Kinaset Therapeutics at?
Kinaset Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Kinaset Therapeutics — Funding & Investors." VCBacked, January 10, 2026, https://www.vcbacked.co/company/kinaset-therapeutics. Accessed June 3, 2026.
APA
VCBacked. (2026). Kinaset Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/kinaset-therapeutics
Wikipedia (cite web)
{{cite web |title=Kinaset Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kinaset-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K